Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.
IPO Year: 2000
Exchange: NASDAQ
Website: axcelis.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/8/2024 | Buy → Hold | The Benchmark Company | |
| 5/3/2024 | $130.00 | Hold → Buy | Craig Hallum |
| 12/15/2023 | Buy → Neutral | BofA Securities | |
| 9/15/2023 | $225.00 | Buy | BofA Securities |
| 8/4/2023 | $140.00 → $175.00 | Buy → Hold | Craig Hallum |
| 6/14/2023 | Buy → Hold | Needham | |
| 6/5/2023 | Outperform | William Blair | |
| 2/28/2023 | $150.00 | Buy | Loop Capital |
| 1/5/2023 | $77.00 → $100.00 | Buy | Needham |
| 12/10/2021 | $82.00 → $87.00 | Buy | B. Riley Securities |
BEVERLY, Mass., Nov. 19, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that management will participate in the following investor conferences: 2024 Wells Fargo TMT Summit, taking place at the Terranea Resort in Rancho Palos Verdes, CA on December 3 and 4, 2024. Axcelis management will host one-on-one meetings on December 3, 2024, with interested investors. For more information on the conference, or to schedule a one-on-one meeting, please contact a Wells F
Revenue of $256.6 millionOperating margin of 18.3% Diluted earnings per share of $1.49BEVERLY, Mass., Nov. 6, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2024. The Company reported third quarter revenue of $256.6 million, compared to $256.5 million for the second quarter of 2024. Gross margin for the quarter was 42.9%, compared to 43.8% in the second quarter. Operating profit for the quarter was $46.9 million, compared to $52.8 million for the second quarter. Net income for the quarter was $48.6 million, or $1.49 per diluted share, compared to $50.9 million, or $1.55 per diluted share in the second
BEVERLY, Mass., Oct. 16, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2024 on Wednesday, November 6, 2024, at 4:00 p.m. ET. The Company will host a call to discuss the results for the third quarter 2024 on Thursday, November 7, 2024, at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here: https://register.vevent.com/register/BI64036dd04ee74de4bea3e1ba939fae67
BEVERLY, Mass., Sept. 24, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participating in the International Conference on Silicon Carbide and Related Materials (ICSCRM 2024) taking place September 29 - October 4, 2024, at the Raleigh Convention Center in North Carolina. At the event, Axcelis' management will be available for one-on-one meetings.President and CEO of Axcelis, Dr. Russell Low, said, "We're excited to participate in ICSCRM 2024, one of the most important technology forums in the power market. Axcelis' Purion™ Power Series is the technology leader in this market, due
BEVERLY, Mass., Sept. 4, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a top-level Platinum Sponsor at the International Conference on Ion Implantation Technology 2024 (IIT 2024) taking place September 23-26 at the Toyama International Conference Center in Japan. IIT 2024 is the 24th Conference in the biennial series focused on the major challenges in current and emerging technologies related to implant/doping and annealing processes, device applications, equipment, metrology and modeling.
Showcase Features the Purion and GSD Ovation Series of Ion Implanters Designed to Deliver Significant Technology and Manufacturing Advantages BEVERLY, Mass., Aug. 29, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its Purion™ and GSD Ovation™ Series of ion implanters at the inaugural SEMICON India 2024, India's premier semiconductor event. The conference and exhibition are being held September 11-13, at the India Expo Mart (IEML) in Greater Noida, Delhi, India. Axcelis will be in Booth #H1T11.
BEVERLY, Mass., Aug. 8, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences, at which management will be available for one-on-ones and small group meetings. The 5th Annual Needham Virtual Semiconductor & SemiCap 1x1 Conference on Thursday, August 22nd.The Jefferies Semiconductor, IT Hardware, Communications Software and Infrastructure Summit on Tuesday, August 27th at the Four Seasons Ho
Revenue of $256.5 millionOperating margin of 20.6% Diluted earnings per share of $1.55 BEVERLY, Mass., July 31, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the second quarter ended June 30, 2024. The Company reported second quarter revenue of $256.5 million, compared to $252.4 million for the first quarter of 2024. Gross margin for the quarter was 43.8%, compared to 46.0% in the first quarter. Operating profit for the quarter was $52.8 million, compared to $56.5 million for the first quarter. Net income for the quarter was $50.9 million, or $1.55 per diluted share, compared to $51.6 million, or $1.57 per diluted share in the first quart
BEVERLY, Mass., July 17, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the second quarter 2024 on Wednesday, July 31, 2024, at 4:00 p.m. ET. The Company will host a call to discuss the results for the second quarter 2024 on Thursday, August 1, 2024, at 8:30 a.m. ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here: https://register.vevent.com/register/BIc2d772b56d7b46c0a39772ba7468e5a0
BEVERLY, Mass., July 9, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced preliminary financial results for the second quarter of 2024. The Company now expects revenue to be greater than $252 million, and diluted earnings per share to be greater than $1.38, compared to the Company's previously issued revenue guidance of $245 million and diluted earnings per share of $1.30. In addition, the Company continues to expect second half performance to be stronger than the first half, slightly weighted towards the fourth quarter.
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
The Company Announces Planned Retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy BEVERLY, Mass., June 27, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today named David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, assuming responsibility for the role in July 2024. The Company also announced the retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. Mr. Lawson plans to retire in July 2024 and will remain as a Senior Advisor through July 2025.
BEVERLY, Mass., April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a successful Purion H200™ SiC medium energy implanter evaluation closure at leading power device chipmakers located in Japan. The systems will be used for 150mm and 200mm production of silicon carbide power devices supporting automotive, industrial, energy, and other power intensive applications. Greg Redinbo,
SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company's Board of Directors effective immediately. Ms. Fallon will also become a member of the Company's Audit Committee. Ms. Fallon is the Executive Vice President, HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (NASDAQ:ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position sin
BEVERLY, Mass., Jan. 12, 2021 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today provided updated financial guidance for the fourth quarter of 2020. The Company expects revenue for the fourth quarter of 2020 to be approximately $120 million, above the $110 million prior guidance. Gross margin of approximately 43% is up from the previous gross margin guidance of 41%. As a result, the Company expects earnings per diluted share of approximately $0.32, up from the previous guidance of approximately $0.21. Cash will be greater than $200 million. Strong performance by our CS&I business contr
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
4/A - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4/A - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
The Benchmark Company downgraded Axcelis Tech from Buy to Hold
Craig Hallum upgraded Axcelis Tech from Hold to Buy and set a new price target of $130.00
BofA Securities downgraded Axcelis Tech from Buy to Neutral
BofA Securities initiated coverage of Axcelis Tech with a rating of Buy and set a new price target of $225.00
Craig Hallum downgraded Axcelis Tech from Buy to Hold and set a new price target of $175.00 from $140.00 previously
Needham downgraded Axcelis Tech from Buy to Hold
William Blair initiated coverage of Axcelis Tech with a rating of Outperform
Loop Capital initiated coverage of Axcelis Tech with a rating of Buy and set a new price target of $150.00
Needham reiterated coverage of Axcelis Tech with a rating of Buy and set a new price target of $100.00 from $77.00 previously
B. Riley Securities reiterated coverage of Axcelis Tech with a rating of Buy and set a new price target of $87.00 from $82.00 previously
10-Q - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
10-Q - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
144 - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SD - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
10-Q - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
Revenue of $256.6 millionOperating margin of 18.3% Diluted earnings per share of $1.49BEVERLY, Mass., Nov. 6, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2024. The Company reported third quarter revenue of $256.6 million, compared to $256.5 million for the second quarter of 2024. Gross margin for the quarter was 42.9%, compared to 43.8% in the second quarter. Operating profit for the quarter was $46.9 million, compared to $52.8 million for the second quarter. Net income for the quarter was $48.6 million, or $1.49 per diluted share, compared to $50.9 million, or $1.55 per diluted share in the second
BEVERLY, Mass., Oct. 16, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2024 on Wednesday, November 6, 2024, at 4:00 p.m. ET. The Company will host a call to discuss the results for the third quarter 2024 on Thursday, November 7, 2024, at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here: https://register.vevent.com/register/BI64036dd04ee74de4bea3e1ba939fae67
Revenue of $256.5 millionOperating margin of 20.6% Diluted earnings per share of $1.55 BEVERLY, Mass., July 31, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the second quarter ended June 30, 2024. The Company reported second quarter revenue of $256.5 million, compared to $252.4 million for the first quarter of 2024. Gross margin for the quarter was 43.8%, compared to 46.0% in the first quarter. Operating profit for the quarter was $52.8 million, compared to $56.5 million for the first quarter. Net income for the quarter was $50.9 million, or $1.55 per diluted share, compared to $51.6 million, or $1.57 per diluted share in the first quart
BEVERLY, Mass., July 17, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the second quarter 2024 on Wednesday, July 31, 2024, at 4:00 p.m. ET. The Company will host a call to discuss the results for the second quarter 2024 on Thursday, August 1, 2024, at 8:30 a.m. ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here: https://register.vevent.com/register/BIc2d772b56d7b46c0a39772ba7468e5a0
Revenue, Gross Margin and EPS Beat Guidance BEVERLY, Mass., May 1, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the first quarter ended March 31, 2024. The Company reported first quarter revenue of $252.4 million, compared to $310.3 million for the fourth quarter of 2023. Gross margin for the quarter was 46%, compared to 44.4% in the fourth quarter. Operating profit for the quarter was $56.5 million, compared to $79.1 million for the fourth quarter. Net income for the quarter was $51.6 million, or $1.57 per diluted share,
BEVERLY, Mass., April 11, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) will release financial results for the first quarter of 2024 on Wednesday, May 1, 2024, at 4:00 p.m. Eastern Time (ET). The Company will host a call to discuss the results for the first quarter 2024 on Thursday, May 2, 2024, at 8:30 a.m. ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here:https://register.vevent.com/register/BI3597bb3b60b345b3a930f23a61948ca3. Webcast replays will be available for 30 days following the call. About Axcelis:Axcelis (NASDAQ:A
Record Revenue for 2023, Achieving Year-Over-Year Growth of 23% BEVERLY, Mass., Feb. 7, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2023. Highlights include: Record full year revenue, operating profit and EPS, enabling the Company to surpass its $1.1 billion revenue model.Continued strong growth from the Purion Power Series™ product line.Significant increase in Purion™ installed base drove record CS&I revenue.Year-end systems backlog of $1.2 billion.For the full year 202
BEVERLY, Mass., Oct. 12, 2023 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) will release financial results for the third quarter of 2023 on Wednesday, November 1, 2023, at 4:00 p.m. Eastern Time (ET). The Company will host a call to discuss the results for the third quarter 2023 on Thursday, November 2, 2023, at 8:30 a.m. ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here: https://register.vevent.com/register/BI1a199f2035664eafaa3226da79b560e5. Webcast replays will be available for 30 days following the call. About Axcelis:Axceli
Financial Results Exceed Guidance Driven by Strong Purion Demand and Strength in Power Devices BEVERLY, Mass., Aug. 2, 2023 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the second quarter of 2023. Highlights include: The Company reported second quarter revenue of $274.0 million, compared to $254.0 million for the first quarter of 2023.Operating profit for the quarter was $63.7 million, compared to $51.4 million for the first quarter.Net income for the quarter was $61.6 million, or $1.86 per diluted share, compared to $47.7 mill
BEVERLY, Mass., July 18, 2023 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) will release financial results for the second quarter of 2023 on Wednesday, August 2, 2023, at 4:00 p.m. Eastern Time (ET). The Company will host a call to discuss the results for the second quarter 2023 on Thursday, August 3, 2023, at 8:30 a.m. ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here: https://register.vevent.com/register/BI9757e7e7d17f4188872f4146e314ba26. Webcast replays will be available for 30 days following the call. About Axcelis: Axcelis
Axcelis Technologies's (NYSE:ACLS) short percent of float has risen 19.37% since its last report. The company recently reported that it has 2.19 million shares sold short, which is 9.92% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.6 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short in
DA Davidson analyst Thomas Diffely maintains Axcelis Technologies (NASDAQ:ACLS) with a Buy and raises the price target from $150 to $175.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler cut the price target for Schlumberger Limited (NYSE:SLB) from $71 to $66. Piper Sandler analyst Luke Lemoine maintained an Overweight rating. SLB shares gained 0.5% to close at $46.42 on Friday. See how other analysts view this stock. Oppenheimer boosted the price target for The Trade Desk, Inc. (NASDAQ:TTD) from $105 to $120. Oppenheimer analyst Jason Helfstein maintained an Outperform rating. Trade Desk shares gained 0.9% to close at $99.44 on Friday. See how other analysts view thi
Benchmark analyst Mark Miller maintains Axcelis Technologies (NASDAQ:ACLS) with a Buy and raises the price target from $170 to $180.
U.S. stocks closed higher on Friday, with the Dow Jones index topping the key 40,000 mark during the session. The 30-stock blue-chip index gained around 1.6% last week. Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst’s opinion to trust. Benzinga’s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga display
B. Riley Securities analyst Craig Ellis maintains Axcelis Technologies (NASDAQ:ACLS) with a Buy and raises the price target from $175 to $190.
Craig-Hallum analyst Christian Schwab maintains Axcelis Technologies (NASDAQ:ACLS) with a Buy and raises the price target from $130 to $174.
B of A Securities analyst Duksan Jang maintains Axcelis Technologies (NASDAQ:ACLS) with a Neutral and raises the price target from $150 to $160.
Needham analyst Charles Shi reiterates Axcelis Technologies (NASDAQ:ACLS) with a Hold.